Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1956 1
1957 1
1960 1
1965 1
1966 1
1967 2
1968 1
1971 1
1973 1
1975 1
1977 2
1978 2
1979 2
1980 1
1981 2
1982 7
1983 2
1985 3
1986 2
1987 6
1988 10
1989 10
1990 4
1991 4
1992 5
1993 5
1994 9
1995 5
1996 8
1997 4
1998 4
1999 15
2000 5
2001 6
2002 7
2003 3
2004 5
2005 7
2006 11
2007 16
2008 15
2009 17
2010 14
2011 17
2012 19
2013 14
2014 24
2015 18
2016 22
2017 23
2018 30
2019 24
2020 32
2021 49
2022 50
2023 41
2024 39
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

580 results

Results by year

Filters applied: . Clear all
Page 1
Biological treatment for erythrodermic psoriasis.
Dogra S, Mehta H. Dogra S, et al. Expert Opin Biol Ther. 2022 Dec;22(12):1531-1543. doi: 10.1080/14712598.2022.2128669. Epub 2022 Sep 28. Expert Opin Biol Ther. 2022. PMID: 36154361 Review.
INTRODUCTION: Erythrodermic psoriasis (EP) is an extreme and potentially life-threatening form of psoriasis in which most or all of the body surface area is affected by psoriasis. It occurs in 1-2% of patients with psoriasis and is less responsi …
INTRODUCTION: Erythrodermic psoriasis (EP) is an extreme and potentially life-threatening form of psoriasis in which mo …
Treatment of erythrodermic psoriasis with biologics: A systematic review.
Carrasquillo OY, Pabón-Cartagena G, Falto-Aizpurua LA, Santiago-Vázquez M, Cancel-Artau KJ, Arias-Berrios G, Martín-García RF. Carrasquillo OY, et al. J Am Acad Dermatol. 2020 Jul;83(1):151-158. doi: 10.1016/j.jaad.2020.03.073. Epub 2020 Apr 2. J Am Acad Dermatol. 2020. PMID: 32247872
BACKGROUND: Biologic medications for plaque psoriasis have been used to treat erythrodermic psoriasis (EP). Since the guidelines for management of EP were published, new biologic medications have been approved for the treatment of plaque psoriasis. ... …
BACKGROUND: Biologic medications for plaque psoriasis have been used to treat erythrodermic psoriasis (EP). Since the g …
Psoriasis: a brief overview.
Raharja A, Mahil SK, Barker JN. Raharja A, et al. Clin Med (Lond). 2021 May;21(3):170-173. doi: 10.7861/clinmed.2021-0257. Clin Med (Lond). 2021. PMID: 34001566 Free PMC article.
Psoriasis is a clinically heterogeneous lifelong skin disease that presents in multiple forms such as plaque, flexural, guttate, pustular or erythrodermic. An estimated 60 million people have psoriasis worldwide, with 1.52% of the general population affected
Psoriasis is a clinically heterogeneous lifelong skin disease that presents in multiple forms such as plaque, flexural, guttate, pust
Updates on the Treatment of Erythrodermic Psoriasis.
Lo Y, Tsai TF. Lo Y, et al. Psoriasis (Auckl). 2021 Jun 9;11:59-73. doi: 10.2147/PTT.S288345. eCollection 2021. Psoriasis (Auckl). 2021. PMID: 34136373 Free PMC article. Review.
Erythrodermic psoriasis (EP) is a rare variant of psoriasis, which is potentially life threatening and often resistant to conventional therapy. Biologics have revolutionized the treatment of plaque-type psoriasis, and shown promise in EP. However, due
Erythrodermic psoriasis (EP) is a rare variant of psoriasis, which is potentially life threatening and often resistant
Erythrodermic psoriasis improved by Tildrakizumab.
Trevisan G, Germi L, Naldi L. Trevisan G, et al. Dermatol Reports. 2022 Nov 23;14(4):9448. doi: 10.4081/dr.2022.9448. eCollection 2022 Nov 21. Dermatol Reports. 2022. PMID: 36483225 Free PMC article.
Erythrodermic psoriasis (EP), clinically defined as prominent erythema and scaling affecting almost the entire skin surface, is a severe form and a rare variant of psoriasis. ...Newer biological drugs, including anti-TNF, anti-IL- 17, and anti-IL-23 agents, e
Erythrodermic psoriasis (EP), clinically defined as prominent erythema and scaling affecting almost the entire skin surface, i
Psoriasis.
Weigle N, McBane S. Weigle N, et al. Am Fam Physician. 2013 May 1;87(9):626-33. Am Fam Physician. 2013. PMID: 23668525 Free article. Review.
Psoriasis is a chronic inflammatory skin condition that is often associated with systemic manifestations. ...Diagnosis is based on the typical erythematous, scaly skin lesions, often with additional manifestations in the nails and joints. Plaque psoriasis is the mos
Psoriasis is a chronic inflammatory skin condition that is often associated with systemic manifestations. ...Diagnosis is based on th
[Erythrodermic psoriasis].
Rollin L, Rioual N, Aubret J, Dolghin M, Fouilland X. Rollin L, et al. Rev Prat. 2024 Jan;74(1):56-57. Rev Prat. 2024. PMID: 38329255 French. No abstract available.
Erythrodermic psoriasis after COVID-19 vaccination.
Trepanowski N, Coleman EL, Melson G, Brem CE, Lam CS. Trepanowski N, et al. JAAD Case Rep. 2022 Oct;28:123-126. doi: 10.1016/j.jdcr.2022.07.041. Epub 2022 Aug 10. JAAD Case Rep. 2022. PMID: 35966353 Free PMC article. No abstract available.
Erythrodermic psoriasis.
Mumoli N, Vitale J, Gambaccini L, Sabatini S, Brondi B, Cei M. Mumoli N, et al. QJM. 2014 Apr;107(4):315. doi: 10.1093/qjmed/hct139. Epub 2013 Jun 12. QJM. 2014. PMID: 23764512 No abstract available.
Erythrodermic Psoriasis Managed with Risankizumab.
Alajlan A, Madani A, Qadoumi TA, Aljaloud A, Alessa M. Alajlan A, et al. Case Rep Dermatol. 2022 Aug 19;14(2):219-224. doi: 10.1159/000525774. eCollection 2022 May-Aug. Case Rep Dermatol. 2022. PMID: 36158862 Free PMC article.
Erythrodermic psoriasis (EP) is a severe, often refractory, variant of psoriasis. Due to the high morbidity and mortality rate associated with EP and other causes of erythroderma, they are often classified as dermatologic emergencies. ...
Erythrodermic psoriasis (EP) is a severe, often refractory, variant of psoriasis. Due to the high morbidity and mortali
580 results